Orchestra BioMed Holdings, Inc. (OBIO) Operating cash flow 2021–2025
Orchestra BioMed Holdings, Inc. (OBIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$49.0MFY2025 · since FY2021: -$272,362 → -$49.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.0M | +3.2% |
| FY2024 | -$50.6M | -9.6% |
| FY2023 | -$46.1M | -57.5% |
| FY2022 | -$29.3M | -10653.7% |
| FY2021 | -$272,362 | — |
Source: SEC XBRL filings · For reference only · Not investment advice